Skip to main content
Clinical Trials/NCT05135169
NCT05135169
Completed
Not Applicable

Multi-organ Transit Time Acquisition Using Contrast Ultrasound

Vanderbilt University Medical Center1 site in 1 country16 target enrollmentMarch 3, 2022

Overview

Phase
Not Applicable
Intervention
Definity Suspension for Injection
Conditions
Healthy
Sponsor
Vanderbilt University Medical Center
Enrollment
16
Locations
1
Primary Endpoint
transit time
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Registry
clinicaltrials.gov
Start Date
March 3, 2022
End Date
June 30, 2025
Last Updated
9 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ken Monahan

Assistant Professor

Vanderbilt University Medical Center

Eligibility Criteria

Inclusion Criteria

  • at least 18 years old
  • able to give informed consent

Exclusion Criteria

  • Known allergic reaction to Definity ultrasound contrast
  • Pregnancy/Nursing - as assessed/disclosed by the participant

Arms & Interventions

Contrast administration

Intervention: Definity Suspension for Injection

Outcomes

Primary Outcomes

transit time

Time Frame: during procedure

time it takes for contrast to traverse an organ

Study Sites (1)

Loading locations...

Similar Trials